Pharmalex India Private Limited - Company overview

Registered with ROC Delhi on 23 May 2013, Pharmalex is an active private company owned by a foreign company that has been around for about 1…

2013-05-23 Paschim Vihar, Delhi Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹50–100 Cr
▲ 10.2%
FY 2023
PROFIT / LOSS
₹5–10 Cr
▼ -39.8%
FY 2023
EBITDA
₹5–10 Cr
▼ -47.5%
FY 2023
NET WORTH
₹10–25 Cr
▲ 35.5%
FY 2023
TOTAL ASSETS
₹25–50 Cr
▲ 31.0%
FY 2023
EMPLOYEE COUNT
261–270
OPEN CHARGES
-
-
PAID-UP CAPITAL
20.00 Lakh
AUTHORISED CAPITAL
20.00 Lakh
COMPANY AGE
13 Years 4 Months
since 2013-05-23
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-09-30
ACTIVE GST
3
Updated: 2025-06-25 21:52:14
TOTAL MONEY RAISED
₹10–50 Lakh
SATISFIED CHARGES
-
-

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Pharmalex covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Low risk
93/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (88), financial health (95), director (95) and company-foundation signals.
  • Operating for 13+ years.
Compliance Score Low risk
88/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2025 - slightly behind.
Financial Health Score Low risk
95/100
Profitability, leverage and liquidity from filed statements.
  • Profitable in FY 2023.
  • Positive net worth.
Director Risk Score Low risk
95/100
Board strength, DIN status and churn.
  • 2 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Pharmalex Company identity, industry, contact, and registration details from MCA and company records.

Registered with ROC Delhi on 23 May 2013, Pharmalex is an active private company owned by a foreign company that has been around for about 13 years. Its registered office is at A-6/250, Paschim Vihar, Delhi. It was earlier known as Yes Regulatory Healthcare Services India Private Limited.

Its filings describe the main line of business as other professional, scientific and technical activities, which made up 100% of turnover.

It has two directors: Christopher . Gauglitz and Pawan Kumar Suri. The longest-serving is Pawan Kumar Suri, on the board since 2019; the most recent to join is Christopher . Gauglitz, appointed in September 2023. Pawan Kumar Suri is the managing director. 11 former directors are on record; the most recent to leave was Rajesh Rajkumar Jain in September 2023. The same directors also sit on the board of Cunesoft India Private Limited.

Authorised and paid-up capital are both ₹20 lakh, so the full authorised amount has been issued. The last AGM on record was on 30 September 2025, for accounts made up to 31 March 2025. No charges (secured loans) are registered against it.

Healthcare ••••••••
  • Location A-6/250, Paschim Vihar, Delhi - 110063
  • Website pharmalex.com
LinkedIn Twitter
Name History
Legal NamePharmalex India Private Limited
CIN / LLPINU85100DL2013FTC252553
Company No.252553
ClassificationPrivate Limited Foreign Company Incorporated In India
Incorporation Date2013-05-23
Date of AGM2025-09-30
Date of Balance Sheet2025-03-31
Listing StatusUnlisted
ROC CodeRoc Delhi
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Pharmalex (2) Current board members from MCA filings, including designation and appointment details.

C
Christopher . Gauglitz
Director | Since 2023-09-04 | DIN: 10263076
P
Pawan Kumar Suri
Managing Director | Since 2019-07-01 | DIN: 08481004

Financial Performance of Pharmalex Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2023
Revenue ₹50–100 Cr ▲ 10.2%
P&L ₹5–10 Cr ▼ -39.8%
EBITDA ₹5–10 Cr ▼ -47.5%
Net worth ₹10–25 Cr ▲ 35.5%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
Professional, Scientific and TechnicalOther professional, scientific and technical activities100

Companies With Common Directors Of Pharmalex Other companies that share directors with this entity, based on MCA and compliance network data.

Board Overlap From MCA / Compliance Filings

Cunesoft India Private Limited 2 Shared Directors

Financial Ratios of Pharmalex Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

9 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Pharmalex Ownership and contribution detail from filings. Full breakdown unlocks with your report.

8 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at Pharmalex EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of Pharmalex GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Pharmalex MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Pharmalex Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pharmalex Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Pharmalex?
MCA does not publish an "owner" field. Pharmalex is run by its directors, Christopher . Gauglitz and Pawan Kumar Suri, with Pawan Kumar Suri as managing director. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Pharmalex?
Pharmalex has two current directors: Christopher . Gauglitz (since September 2023) and Pawan Kumar Suri (since July 2019). Pawan Kumar Suri is the managing director.
What is CIN of Pharmalex?
The CIN of Pharmalex is U85100DL2013FTC252553. Reading it left to right: U means it is not listed, 85100 is the industry code it registered under, DL is Delhi, 2013 is the year it was registered, FTC is the company type and 252553 is its registration number.
When was Pharmalex incorporated?
Pharmalex was incorporated on 23 May 2013 with ROC Delhi. That makes it about 13 years old.
What is the registered address of Pharmalex?
The registered office on MCA records is A-6/250, Paschim Vihar, Delhi - 110063.
What is the current status of Pharmalex?
MCA shows Pharmalex as Active, and its last AGM on record was in September 2025.
What is the contact number or email for Pharmalex?
You can post to its registered office at A-6/250, Paschim Vihar, Delhi - 110063 and use its website, https://pharmalex.com.
What industry or business activity is Pharmalex associated with?
Its MCA filings list the main business as other professional, scientific and technical activities (100% of turnover).
What is paid-up capital and authorised share capital of Pharmalex?
Both authorised and paid-up capital are ₹20 lakh.
When did Pharmalex last file accounts and hold an AGM?
The last AGM on record was on 30 September 2025, and the latest balance sheet is for the year ending 31 March 2025.
Where can I see charges and lenders for Pharmalex?
MCA shows no charges registered against Pharmalex, so no assets are pledged for a registered secured loan.
Have any directors left Pharmalex?
Yes, 11 former directors are on record. The most recent to leave were Rajesh Rajkumar Jain (September 2023), Laurent Couston (September 2023) and Caren Ingrid Martini (September 2023).
Which companies share directors with Pharmalex?
Cunesoft India Private Limited shares at least one director with Pharmalex.
What is the turnover or revenue of Pharmalex?
Based on filed financial statements, the revenue of Pharmalex for FY 2023 was in the ₹50–100 Cr range. That is up 10.2% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Pharmalex?
For FY 2023, the net worth of Pharmalex was in the ₹10–25 Cr range.
How can I get the financial details of Pharmalex?
The latest accounts on record are for FY 2023. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Pharmalex?
The website on record for Pharmalex is https://pharmalex.com.
Which company owns pharmalex.com?
pharmalex.com is the website listed for Pharmalex India Private Limited in its company records.
Pharmalex - is it listed or unlisted?
Pharmalex is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Pharmalex?
Pharmalex is registered with ROC Delhi.
What is the company classification of Pharmalex?
MCA classifies Pharmalex as: Private Limited Foreign Company Incorporated In India.
Does Pharmalex have GST registrations on file?
Yes, 3 active GST registrations are linked to Pharmalex, usually one per state it operates in.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.